Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ketoconazole 20.6 mg/ml;  ;  ;   - shampoo - 2% w/w - active: ketoconazole 20.6 mg/ml       excipient: cocamide diolamine diazolidinyl urea erythrosine hydrochloric acid herb flower fragrance polyethylene glycol distearate purified water sodium laureth sulfate sodium lauril sarcosinate - treatment of seborrhoeic dermatitis and severe dandruff of the scalp in adults.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sildenafil citrate 140.48mg equivalent to 100 mg sildenafil;  ;   - tablet - 100 mg - active: sildenafil citrate 140.48mg equivalent to 100 mg sildenafil     excipient: croscarmellose sodium hypromellose indigo carmine lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose povidone titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sildenafil citrate 35.12mg equivalent to 25 mg sildenafil;  ;   - tablet - 25 mg - active: sildenafil citrate 35.12mg equivalent to 25 mg sildenafil     excipient: croscarmellose sodium hypromellose indigo carmine lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose povidone titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sildenafil citrate 70.24mg equivalent to 50 mg sildenafil;  ;   - tablet - 50 mg - active: sildenafil citrate 70.24mg equivalent to 50 mg sildenafil     excipient: croscarmellose sodium hypromellose indigo carmine lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose povidone titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lansoprazole 15mg (lansoprazole (r,s racemic mixture));   - capsule - 15 mg - active: lansoprazole 15mg (lansoprazole (r,s racemic mixture))   excipient: gelatin   hypromellose macrogol 6000 mannitol meglumine methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc purified water   quinoline yellow   sodium laurilsulfate sugar spheres titanium dioxide     - healing and long-term management of reflux oesophagitis healing and maintenance therapy for patients with duodenal ulcer healing of benign gastric ulcer lansoprazole is also effective in patients with benign peptic lesions that do not respond to h2-receptor antagonists

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lansoprazole 30mg (lansoprazole (r,s racemic mixture) );   - capsule - 30 mg - active: lansoprazole 30mg (lansoprazole (r,s racemic mixture) )   excipient: gelatin   hypromellose macrogol 6000 mannitol meglumine methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc sodium laurilsulfate sugar spheres titanium dioxide     water   - healing and long-term management of reflux oesophagitis healing and maintenance therapy for patients with duodenal ulcer healing of benign gastric ulcer lansoprazole is also effective in patients with benign peptic lesions that do not respond to h2-receptor antagonists

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 100mg;   - capsule - 100 mg - active: temozolomide 100mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 140mg;   - capsule - 140 mg - active: temozolomide 140mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 180mg;   - capsule - 180 mg - active: temozolomide 180mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 20mg;   - capsule - 20 mg - active: temozolomide 20mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.